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Abstract 
Objective:  
To assess the agreement of tonometers available for clinical practice with Goldmann 
applanation tonometer (GAT), the most commonly accepted reference device. 
Design: 
A systematic review and meta-analysis of directly comparative studies assessing the 
agreement of one or more tonometers with the reference tonometer (GAT). 
Participants: 
A total of 11,582 participants (15,525 eyes) were included. 
Methods: 
Summary 95% limits of agreement were produced for each comparison. 
Main Outcome measures: 
Agreement, recordability and reliability. 
Results: 
A total of 102 studies, including 130 paired comparisons were included representing eight 
tonometers (Dynamic Contour Tonometer, Non-contact Tonometer [NCT], Ocular Response 
Analyser, Ocuton S, Handheld Applanation Tonometer, Rebound Tonometer, Transpalpebral 
and Tonopen). The agreement (95% limits) appeared to vary across tonometers; 0.2 mmHg (-
3.8 to 4.3 mmHg) for NCT to 2.7 mmHg (-4.1 to 9.6 mmHg) for Ocuton S. The estimated 
proportion within 2mmHg of GAT ranged from 33% (Ocuton S) to 66% and 59% (NCT and 
Handheld applanation tonometers respectively). Substantial inter- and intra-observer 
variability was observed for all tonometers.  
Conclusions: 
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NCT or Handheld applanation tonometers appear to achieve a measurement closest to GAT.  
However, there was substantial variability in measurements both within and between studies. 
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Manuscript 
  
Background 
Raised intraocular pressure (IOP) is the most important risk factor for developing glaucoma 
and is the only one which is treatable. The risk of developing glaucoma and worsening of 
existing disease rises with increasing IOP.1-4  In the United Kingdom (UK),  there is 
considerable debate about the role and optimal organisation of a monitoring service for those 
patients with ocular hypertension, and whether other health professionals (e.g., nurses, 
optometrists) might be safely involved in measuring IOP. To be used in such a setting a 
tonometer needs be accurate, precise and easy to use. 
 
Goldmann applanation tonometer (GAT), a contact tonometer, is currently the most widely 
used tonometer by ophthalmologists. A very thick or thin cornea can lead to measurement 
error in tonometry, including GAT.5;6 New tonometers are available which account for the 
biomechanical properties and thickness of the cornea. In addition, non-invasive self 
measurement devices are available and may be highly appropriate and relevant as monitoring 
devices.  
 
The aim of this systematic review was to compare the agreement of the tonometers used in 
clinical practice with GAT as the reference tonometer.  
 
Methods 
Directly comparative studies, i.e., those which assessed the agreement of one or more 
tonometers, compared with the reference standard tonometer (GAT) in the same group of 
people (paired data) were included. Clinic (e.g., case-control and cohort design) and 
population (e.g., cross-sectional) studies were eligible provided they incorporated paired data 
for GAT and at least one other tonometer which could be used in clinical practice. The 
following  tonometers were not included as they were  either not commercially available or  
were judged not suitable for monitoring ocular hypertension in routine clinical practice: 
Applanation resonance tonometer;7 Ocular blood flow instrument;8 Schoitz;9 Smartlens;10 
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pneumatonometer;11 and manometry.12 Studies published in a non-English language and 
conference abstracts were excluded. All patients aged 16 years and over, including those with 
a diagnosis of ocular hypertension or glaucoma or representative of the general population, 
were eligible for inclusion. Where the age range was not reported confirmation from the 
authors was sought. If there was still uncertainty, a formula was applied (Mean-3SD≥16; or 
median-3*[IQR/1.35]≥16), where SD and IQR are the standard deviation and inter-quartile 
range respectively) to assess inclusion and prevent exclusion purely on the failure to report 
the age. Participants with corneal abnormalities were excluded (corneal pathology including: 
keratoconus; bullous keratoplasty; or post corneal grafts). Measurements performed by any 
type of examiner (e.g., optometrists; ophthalmologists; nurses; technicians; or patients) were 
considered. The outcomes of interest were agreement (mean difference and limits of 
agreement) between a tonometer and the reference standard, the reliability (inter- and intra-
observer variation) associated with measurements, and the proportion of participants with a 
recorded IOP measurement hereafter termed ‘recordability’. 
 
Sensitive electronic searches using both thesaurus controlled and text terms were conducted 
to identify reports of published and ongoing studies on the reliability and agreement of 
tonometers. The following bibliographic databases were searched from 1987 until February 
2010: Medline; Medline-In Process; Embase; Science Citation Index; Biosis; and the 
Cochrane Central Register of Controlled Trials. In addition, the websites of key journals were 
screened for relevant in-press publications. Additional searches were undertaken in current 
research registers including: Clinical Trials; Current Controlled Trials; and WHO International 
Clinical Trials Registry Platform. An Internet search using Copernic Agent was also 
undertaken and included key professional organisations and manufacturers of tonometers. 
The reference list of included studies was also checked. Full details of the search strategies 
used are available from the authors  as is the protocol. 
 
Two reviewers independently screened the titles and abstracts (if available) of all reports 
identified by the electronic searches. Full text copies of all studies deemed to be potentially 
relevant were obtained and independently assessed for inclusion by two reviewers. Two 
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reviewers independently extracted data on study design, participant characteristics, type of 
tonometer used and outcome data. When outcome data were provided either per eye 
(right/left) right eye data only was used. If different versions of the same technology were 
reported, data on the most recent version were included.  We conducted a 20% check of all 
extracted data. Quality of included studies was assessed using a modified checklist adapted 
from QUADAS tool for diagnostic studies13 and a checklist for agreement studies.14 
Discrepancies were resolved by discussion or arbitration.  
 
The primary outcome agreement was assessed by calculating summary 95% limits of 
agreement (LoA).15 The 95% LoA interval was calculated for each candidate tonometer from 
pooled estimates of the mean difference (systematic difference) between a tonometer and a 
reference standard and of the corresponding variability of agreement (random error). Pooled 
estimates of mean difference and random error were calculated using the DerSimonian and 
Laird random effects method.16  Imputation of within participant correlation coefficients to 
allow calculation of the standard deviation of differences (SDdiff) was employed, if required, 
using mean correlation of estimates from other studies of the same tonometer.  The 95% 
limits of agreement (LoA) and the proportion of measurements within 2mmHg of GAT was 
estimated from the pooled difference and standard deviation assuming a normal distribution. 
Sensitivity analyses included a fixed-effect analysis and/or imputation of correlations using the 
minimum correlation coefficient reported from the studies assessing the same tonometer. An 
approximate 95% prediction interval was calculated for the mean difference and the SDdiff 
parameters using the estimated tau (standard deviation of the study level distribution) from 
the random effects analysis to quantify the impact of between study heterogeneity.  It 
provides a range of plausible values for a future study, based upon the current studies 
(pooled parameter estimate±1.96*tau). 
 
Further sensitivity analyses looked at the impact of excluding studies which used suboptimal 
methods according to our quality assessment tool (i.e., where at least one of the requirements 
is clearly not met) and excluding studies with data clustered within persons.  An additional 
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analysis was conducted to correct for repeated measurements by using reported estimates of 
within-participant variation.17 
 
Heterogeneity between the study estimates in the meta-analyses was explored by visual 
inspection of forest plots, calculation of tau and I2 statistics. Possible reasons for 
heterogeneity were explored through pre-specified subgroup analyses of central corneal 
thickness, previous corneal refractory surgery, type of examiner and IOP level with 
corresponding subgroup meta-analyses being conducted. Due to the observed level of 
heterogeneity, a further subgroup analysis investigated the impact of manufacturers in studies 
where multiple manufacturers produced the same type of tonometer. Formal comparison 
between subgroups was not conducted due to the large level of heterogeneity in the main 
analyses. Recordability data were tabulated with no quantitative analysis conducted. 
Reliability data was collected for GAT and the tonometers where reported. No formal 
synthesis of data was carried out as a variety of measures (e.g., intracluster correlation 
coefficients and repeatability coefficients) were used.  
 
Data were validated and prepared using Microsoft Excel (Microsoft Corporation, Redmond, 
WA, USA) and SPSS version 18 (IBM Corporation, NY, USA). Meta-analyses were carried 
out using the metan command in Stata version 11 (Stata Corporation, College Station, TX, 
USA).   
 
Results 
A total of 642 titles and abstracts were identified from the search of which 143 were selected 
for full text assessment. An additional 46 potentially eligible studies were identified from the 
reference lists of included studies. In total, 189 studies were full text assessed. 102 studies 
(130 paired comparisons) involving 11,582 participants (15,525 eyes) were included in the 
review. Studies included a variety of individuals; both patient and non-diseased cases, some 
with treatment and untreated cases of ocular hypertension and glaucoma. A table of 
characteristics of included studies is available from the authors on request. Eighty seven 
reports were excluded at the full text assessment stage as they failed to meet one or more of 
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the inclusion criteria in terms of study participants, study design, candidate tonometers and 
reference standard as presented in Figure 1.  
 
Included studies compared the reference standard tonometer– GAT (Haag Streit, Koeniz, 
Switzerland) with eight different types of tonometer: Dynamic contour tonometer - DCT 
(PASCAL®, SMT Swiss Microtechnology, Switzerland); Rebound tonometer - RT (ICare®, 
Helsinki, Finland); TonoPen® (Mentor O & O Inc., Santa Barbara, CA, USA [incorporating 
Bio-Rad]; Medtronic Solan, Jacksonville, FL, USA (incorporating Xomed);  Intermedics 
Intraocular Inc., Pasadena, CA, USA); Ocuton S (EPSa Elektronik & Präzisionsbau, Saalfeld, 
Germany); Handheld applanation tonometer - HAT (Kowa HA-2, Kowa, Japan; Perkins, Haag 
Streit, Koeniz, Switerland); Non-contact tonometer - NCT (Canon USA Inc., Lake Success, 
NY, USA; Keeler Ltd., Windsor, UK; Nidek Co. Ltd., Gamagori, Japan; Reichert ophthalmic 
instruments, Buffalo, NY, USA; Topcon Corporation, Tokyo, Japan); Ocular response 
analyser – ORA (Reichert Inc, Depew, NY, USA); Transpalpebral tonometer which includes 
the Pressure phosphene tonometer (Proview eye pressure monitor®, Bausch & Lomb Inc., 
Rochester, NY, USA) and the TGDc-01® (Ryazan State Instrument-making Enterprise, 
Ryazan, Russia) also known as Diaton® tonometer (BiCOM Inc., Long Beach, NY, USA). 
Quality assessment results are summarised in Figure 2. Apart from participant selection and 
accounting for all participations, it was often uncertain whether individual quality criteria were 
met. Rarely was the non-compliance with a criteria item explicitly reported; for example it was 
clear in only one study that tonometers were not calibrated whereas for most studies this was 
not stated. 
 
Ninety-nine studies (125 paired comparisons) were included in the meta-analyses of 
agreement; three did not report sufficient data. Comparison across tonometers was difficult 
given the indirect nature of the analysis. A summary of the main analyses for all candidate 
tonometers is provided in Tables 1 and 2. The proportion (%) of results within 2mmHg of 
GAT, based upon the main analysis mean difference and random error, is also presented. 
Based upon the meta-analyses, the expected difference varied across tonometers with NCT 
having the smallest expected difference (0.2 mmHg) in contrast to Ocuton S which had the 
Systematic review of agreement of tonometers with GAT 
 9 
largest difference (2.7 mmHg). There was substantial uncertainty for most of the tonometers. 
In terms of the estimated random error, results also varied with HAT and NCT having the 
lowest random error (2.1 mmHg) and Ocuton S the largest random error (3.5 mmHg). For all 
tonometers, the 95% LoA stretched from at least 4 mmHg less to 4 mmHg higher with Ocuton 
S and Transpalpebral having the largest intervals. For most tonometers approximately 50% of 
measurements were estimated to be within 2mmHg though it was lowest for Ocuton S (33%). 
NCT and HAT were slightly higher than the others (66% and 59% respectively). 
 
Substantial heterogeneity was observed in estimates between studies. The 95% prediction 
interval for the mean difference and random error are shown in Table 2. All I2 values were 
greater than 80% (figures not shown). The 95% prediction intervals illustrate the impact of the 
heterogeneity between individual studies on the expected mean difference: -4.0 to 9.4 mmHg 
for Ocuton S whereas for NCT the range of values was only -1.4 to 1.9 mmHg. For all 
tonometers bar NCT, a mean difference of greater than 2mmHg compared with GAT fell 
within the 95% prediction interval. Similarly the random error 95% prediction intervals 
illustrate the substantial difference in the level of variability between studies. The sensitivity 
analyses did not have substantial impact upon the results nor did the subgroup analyses 
provide informative results (results for both not shown). 
 
27 studies provided data on recordability. For one RT study of only 36 participants, 
recordability was worryingly low at 50%. For NCT, Ocuton S and Transpalpebral a value in 
the range of 70-90% was observed in a single study which could be considered problematic if 
representative of a monitoring scenario. (Table 3)  Reliability data were reported for all except 
the HAT tonometer, although a variety of metric were reported. Inter- and intra-observer 
reliability data were available for only five of the eight tonometers (37 studies). Generally 
relatively large levels of variability were observed for inter- and intra-reliability with GAT 
appearing to have lower levels of variability than most if not all of the other tonometers. 
 
Discussion 
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We identified a large body of evidence comparing tonometers to GAT. However, poor 
reporting limited the assessment of the quality of the included studies and the synthesis of the 
evidence.  
 
The results of this study suggest that, when compared with GAT, NCT was the tonometer with 
the least amount of variability in IOP.  Approximately two thirds of measurements with NCT 
were estimated to be within 2 mmHg of the GAT measurement.  Second lowest variability was 
observed with HAT, with 59% of measurements within 2 mmHg which was not surprising 
because it is also an applanation tonometer. HAT has the same advantages and limitations 
as GAT, the only substantial difference being that HAT is a portable instrument. Other 
tonometers had about half or more of the measurement differences greater than 2 mmHg.  
Ocuton S appeared to have the lowest agreement with GAT with only a third of 
measurements within 2 mmHg. 
 
Recordability was reported for all tonometers except HAT. Disappointingly, only 27 (26%) 
studies explicitly stated the number of participants for which a measurement was attempted 
as opposed to the number for which a measurement was successfully taken. In general, 
reported recordability was moderate to very high with most studies reporting values of 90% 
and above. Reliability data were available for all tonometers except HAT. There was a clear 
suggestion of sizeable inter- and intra-observer variability for all seven tonometers where data 
were available. It is worth noting that GAT reliability, while often smaller than the 
corresponding study’s candidate tonometer value, was also usually sizeable. This would 
explain the scale of heterogeneity observed in the agreement meta-analyses to some extent, 
although the use of repeated measurement for both GAT and the candidate tonometer should 
have lessened the impact. 
 
Although GAT has a number of limitations for measuring IOP, it is likely to remain the 
standard in secondary care (i.e., hospital setting) for some time.  For this reason, determining 
which tonometers are close to GAT is useful.  Unfortunately, variability between tonometers 
was substantial. Reliability data showed that variability for repeat measurement (including 
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GAT) was also non-negligible. Consistent use of the same tonometer during clinical follow-up 
is arguably almost as important as the choice of tonometer.   
 
To be included in this review, a tonometer had to be judged that it was suitable for monitoring 
ocular hypertension in routine clinical practice and could potentially replace GAT. As such our 
findings are only directly relevant to the eight tonometer types included in this review; 
additional tonometers exist which may be considered as relevant by others.  We chose to 
include studies which directly compared a candidate tonometer against the GAT which we 
used as a reference standard. In principle this should have provided some consistency across 
comparisons though the results perhaps suggest that this standard, though widely accepted, 
is somewhat variable in implementation. Implicitly, any contrast between studies is an indirect 
comparison and suffers from the limitation of such approaches that observed difference may 
reflect at least to some degree the difference amongst the studies (e.g., population) which 
contribute to each comparison. An important finding of the review was the large scale 
heterogeneity between the results of individual studies which assess the same basic 
comparison. The meta-analysis quantified the degree to which findings differed between 
studies and showed the inconsistencies and variations in the published literature. There were 
a number of limitations in the reporting of individual studies which limited the extent to which 
we could accurately represent the evidence. A number of studies included more than one eye 
per participant which resulted in clustering of data within person.18 In addition, studies used 
varying numbers of observations both for the candidate tonometer and the reference 
standard. There are a number of other factors, such as central corneal thickness and the 
underlying IOP level, which are known to influence IOP measurements and potentially 
agreement between tonometers which we were unable to formally investigate these due to 
limitations with the data reported in the published literature. 
 
There is a need to standardise the reporting of comparative studies of tonometers.19 The 
necessary statistics for meta-analysis are often not presented. The reporting is inconsistent 
and in particular basic information is not always presented. Our quality assessment 
highlighted a lack of reporting of key study characteristics and issues such as the clustering of 
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eyes with participants and the number of observations used is regularly ignored. Furthermore 
an in-depth exploration of factors which could influence the pressure measurements is 
needed for the reference standard and candidate tonometers. This could be addressed by  a 
large primary study but also has the potential to be explored in an individual patient data 
meta-analysis.15 Given the level of heterogeneity, it may be the case that a systematic review 
of limit of agreement studies requires very focussed study inclusion criteria akin to those 
recently proposed for diagnostic test accuracy.20  Finally, more in-depth evaluation of the role 
of GAT as the default tonometer in clinical practice seems warranted.  
 
There is a variety of tonometers to evaluate intraocular pressure, and GAT is the current 
reference standard.  NCT or HAT tonometers appear to typically achieve the closest 
measurement to GAT.   
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Table 1  Pooled estimates and summary 95% limits of agreement (mmHg unless 
otherwise stated) 
 
Comparator No. Studies MD 95% CI RE 95% CI 95% LoA % within 2.0 
mmHg 
DCT 32 1.8 1.4 2.2 2.4 2.1 2.6 -2.9 6.5 48% 
HAT 4 -1.2 -2.8 0.4 2.1 1.3 2.8 -5.2 2.8 59% 
NCT 26 0.2 -0.1 0.6 2.1 1.8 2.3 -3.8 4.3 66% 
Ocuton S 3 2.7 -1.2 6.6 3.5 2.4 4.6 -4.1 9.6 33% 
ORA 12 1.5 0.9 2.2 2.8 2.5 3.1 -3.9 7.0 46% 
RT 14 0.9 0.4 1.4 2.6 2.1 3.2 -4.3 6.1 52% 
TonoPen 14 -0.2 -1.0 0.5 3.1 2.5 3.7 -6.2 5.8 48% 
Transpalpebr
al 20 -0.5 -1.3 0.3 3.3 2.8 3.7 -6.9 5.9 46% 
    CI = confidence interval;  
    DCT = dynamic contour tonometer; 
    HAT = handheld applanation tonometer; 
    LoA = limits of agreement; 
    MD = mean Comparator minus mean GAT value; 
    mmHg = millimetres of mercury; 
    NCT = non contact tonometer; 
    ORA = ocular response analyser; 
    RE = the random error (estimated standard deviation of the differences);     
    RT = rebound tonometer 
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Table 2  Pooled estimates with 95% prediction intervals (mmHg unless 
otherwise stated) 
Comparator No. Studies Mean Diff 95% Pred Int Ran Err 95% Pred Int 
DCT 32 1.8 -0.4 4.0 2.4 1.1 3.6 
HAT 4 -1.2 -4.4 2.0 2.1 0.6 3.6 
NCT 26 0.2 -1.4 1.9 2.1 0.8 3.3 
Ocuton S 3 2.7 -4.0 9.4 3.5 1.7 5.3 
ORA 12 1.5 -0.6 3.7 2.8 1.6 4.0 
RT 14 0.9 -0.9 2.7 2.6 0.6 4.7 
TonoPen 14 -0.2 -3.0 2.5 3.1 0.9 5.3 
Transpalpebral 20 -0.5 -3.8 2.8 3.3 1.2 5.4 
    DCT = dynamic contour tonometer; 
    HAT = handheld applanation tonometer; 
    Mean Diff = mean Comparator minus mean GAT value; 
    mmHg = millimetres of mercury; 
    NCT = non contact tonometer; 
    ORA = ocular response analyser; 
    Ran Err = the random error (estimated standard deviation of the differences);   
    RT = rebound tonometer;   
    Pred Int = the prediction interval incorporating estimated between study heterogeneity 
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Table 3 Recordability and study size  
 
Tonometer No. Studies 
 
Recordability   
(%) - median (range) 
Study size  
- median (range) 
DCT 6 99 (93-100)  148 (63-211) 
HAT 0 N/A N/A 
NCT 4 98 (76-100) 81 (45-100) 
Ocuton S 2 88 (82-94) 77 (68-85) 
ORA 2  98 (98) 57 (50-63) 
RT 4 100 (50-100) 145 (36-150) 
TonoPen 3 100 (90-100) 146 (103-208) 
Transpalpebral 9  95 (76-97) 101 (62-213) 
DCT = dynamic contour tonometer; 
HAT = handheld applanation tonometer; 
N/A = non applicable; 
NCT = non contact tonometer; 
ORA = ocular response analyser; 
RT=rebound tonometer 
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Figure 1 Flow diagram of the selection process 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
642 titles / abstract screened 
499 reports excluded 
• 6 conferences abstracts 
• 6 background/discussion 
• 487 clear from abstract/title that inclusion 
criteria were not met 
189 reports selected for full text assessment  
• 143 from abstract screening 
• 46 from reference list of included studies 
87 reports excluded 
• 45 age <16y or uncertain  
• 17 no eligible tonometer 
• 9 comparison of disposable prism  
• 5 no reference standard  
• 4 inclusion of participants with corneal 
disease/surgery 
• 2 correspondence 
• 1 contact lenses wearers 
• 1 eye filled with silicone 
• 1 non human population 
• 1 unclear inclusion/exclusion criteria 
• 1 same study sample as an included study 
102 reports included individual studies 
• 99 sufficient data for meta-analysis 
• 3 insufficient data for meta-analysis 
otherwise met inclusion criteria 
Systematic review of agreement of tonometers with GAT 
 19 
Figure 2 – Quality Assessment of included studies 
 
 
